Hypofractionated Radiotherapy plus Cetuximab in Locally Advanced Head and Neck Cancer

被引：7
|
作者：
Teoh, D. C. [1 ]
Rodger, S. [2 ]
Say, J. [2 ]
Hartley, A. [1 ]
机构：
[1] Queen Elizabeth Hosp, Ctr Canc, Birmingham B15 2TH, W Midlands, England
[2] Univ Birmingham, Fac Med, Birmingham, W Midlands, England
来源：
CLINICAL ONCOLOGY | 2008年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.clon.2008.07.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：717 / 717
页数：1
相关论文
共 50 条
  • [21] Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial
    Magrini, Stefano Maria
    Buglione, Michela
    Corvo, Renzo
    Pirtoli, Luigi
    Paiar, Fabiola
    Ponticelli, Pietro
    Petrucci, Alessia
    Bacigalupo, Almalina
    Crociani, Monica
    Lastrucci, Luciana
    Vecchio, Stefania
    Bonomo, Pierluigi
    Pasinetti, Nadia
    Triggiani, Luca
    Cavagnini, Roberta
    Costa, Loredana
    Tonoli, Sandro
    Maddalo, Marta
    Grisanti, Salvatore
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) : 427 - +
  • [22] Moderately hypofractionated Radiotherapy without Chemotherapy in elderly and frail Patients with locally advanced Head and Neck Cancer
    Fryen, A.
    Brandes, I.
    Wichmann, J.
    Christiansen, H.
    Tavassol, F.
    Durisin, M.
    Merten, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S113 - S114
  • [23] Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer
    Argiris, Athanassios
    Heron, Dwight E.
    Smith, Ryan P.
    Kim, Seungwon
    Gibson, Michael K.
    Lai, Stephen Y.
    Branstetter, Barton F.
    Posluszny, Donna M.
    Wang, Lin
    Seethala, Raja R.
    Dacic, Sanja
    Gooding, William
    Grandis, Jennifer R.
    Johnson, Jonas T.
    Ferris, Robert L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (36) : 5294 - 5300
  • [24] ADVERSE SKIN REACTIONS DURING HIGH. DOSE RADIOTHERAPY PLUS CETUXIMAB IN LOCALLY ADVANCED HEAD AND NECK CANCER: A THERAPEUTIC APPROACH
    Micciche, F.
    Valentini, V.
    Dinapoli, N.
    Autorino, R.
    Balducci, M.
    Bonomo, P.
    De Bari, B.
    De Santis, M.
    Silveri, S. Lanza
    Guerriero, C.
    Capizzi, R.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S250 - S251
  • [25] Treatment Outcome of Cetuximab Compared with Cisplatin during Radical Radiotherapy for Locally Advanced Head and Neck Cancer
    Law, K. S.
    Wong, R. K. Y.
    Yu, E.
    Cheng, A. C. K.
    HONG KONG JOURNAL OF RADIOLOGY, 2016, 19 (02): : 96 - 102
  • [26] COST-EFFECTIVENESS OF CETUXIMAB COMBINED WITH RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER IN TAIWAN
    Chan, A. L.
    Leung, H. W.
    Lin, S. J.
    VALUE IN HEALTH, 2010, 13 (03) : A40 - A40
  • [27] Cetuximab and radiotherapy versus cisplatin and radiotherapy for locally-advanced head and neck cancer: a randomized phase II trial
    Vozy, A.
    Cuenca, X.
    ONCOLOGIE, 2016, 18 (06) : 429 - 430
  • [28] Cost-effectiveness of cetuximab combined with radiotherapy versus radiotherapy alone in locally advanced head and neck cancer in Spain
    Cabellos, Ruth Alvarez
    Cacicedo, Jon
    Capafons, Susana Redondo
    Real, Heidi De los Santos
    Miriam Brines, Julian
    Rubio-Rodriguez, Dario
    Rubio-Terres, Carlos
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2025, 14 (02)
  • [29] Cetuximab and radiotherapy for head and neck cancer
    Posner, MR
    Wirth, LJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06): : 634 - 636
  • [30] Cetuximab in locally advanced head-and-neck cancer: defining the population
    Ho, C.
    CURRENT ONCOLOGY, 2010, 17 (04) : 174 - 177
12345